| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 39.99▲ | 40.35▼ | 40.35▼ | 40.38▼ | 40.37▼ |
| MA10 | 40.28▼ | 40.46▼ | 40.46▼ | 40.65▼ | 39.87▼ |
| MA20 | 40.65▼ | 40.76▼ | 40.78▼ | 40.63▼ | 40.43▼ |
| MA50 | 40.88▼ | 40.49▼ | 40.25▼ | 39.94▼ | 40.09▼ |
| MA100 | 40.31▼ | 40.37▼ | 40.48▼ | 40.48▼ | 38.57▲ |
| MA200 | 40.61▼ | 40.67▼ | 40.52▼ | 40.22▼ | 35.21▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.095▼ | -0.136▼ | -0.145▼ | -0.164▼ | -0.034▼ |
| RSI | 37.407▼ | 39.455▼ | 41.094▼ | 40.363▼ | 45.241▼ |
| STOCH | 13.084▼ | 17.672▼ | 17.672▼ | 38.391 | 62.595 |
| WILL %R | -92.938▼ | -92.938▼ | -92.938▼ | -94.915▼ | -67.647 |
| CCI | -76.514 | -99.356 | -99.285 | -200.239▼ | -13.966 |
|
Thursday, November 19, 2026 05:30 AM
COPENHAGEN, Denmark - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, provides strategy and ...
|
|
Thursday, November 19, 2026 02:56 AM
Evaxion reported a Q3 2026 net loss of US$3.5 million as revenue fell to zero, while advancing its EVX-01, EVX-04 and EVX-05 cancer ...
|
|
Friday, November 06, 2026 05:30 AM
Detection of neoantigen-specific T cells directly ex vivo indicates strong EVX-01-induced immune responsesData further underlines the strong predictive performance of Evaxion’s AI-Immunology™ ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/11/26 | 39.88 | 39.88 | 39.36 | 39.48 | 6,200 |
| 18/11/26 | 40.04 | 40.18 | 39.96 | 40.04 | 4,100 |
| 17/11/26 | 40.96 | 40.97 | 40.21 | 40.21 | 6,100 |
| 16/11/26 | 41.14 | 41.23 | 40.87 | 41.01 | 6,100 |
| 13/11/26 | 41.37 | 41.37 | 41.17 | 41.17 | 7,200 |
| 12/11/26 | 41.19 | 41.28 | 41.08 | 41.11 | 17,700 |
| 11/11/26 | 41.03 | 41.03 | 40.73 | 41.00 | 6,000 |
| 10/11/26 | 40.80 | 40.90 | 40.66 | 40.87 | 5,800 |
| 09/11/26 | 40.94 | 41.45 | 40.94 | 41.25 | 4,500 |
| 06/11/26 | 40.21 | 40.37 | 39.91 | 40.36 | 17,900 |
|
|
||||
|
|
||||
|
|